Acute Bacterial Conjunctivitis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Bacterial Conjunctivitis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Bacterial Conjunctivitis trials you may qualify forA Phase 2, Multi-center, Randomized, Parallel Controlled Study to Evaluate the Clinical Efficacy and Safety of IVIEW-1201 (1.0% Povidone-Iodine) Gel Forming Oph…
Phase III clinical study of non-inferiority, multicenter, double-blind, with comparative group, of parallel groups and randomized. about a ophthalmic topical an…
Evaluation of the clinical and microbial efficacy of 0.6% ISV-403, compared to vehicle in the treatment of bacterial conjunctivitis.
This is a study to investigate a novel drug candidate for the treatment of bacterial conjunctivitis.
The primary objective of this study is to evaluate, through clinical parameters, the effectiveness of your medicine topic Maxinom ® (dexamethasone, neomycin and…
The primary objective of this study is to evaluate, through clinical parameters, the comparative efficacy between topical Tobracort ® (tobramycin 0.3% dexametha…